Searched for
LEUKEMIA DRUG
Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...23 May, 2026, 10.24 PM IST- Alembic Pharma gets USFDA nod for generic cancer, arthritis injectionAlembic Pharmaceuticals has received final approval from the US Food and Drug Administration for its generic methotrexate injection, used t...16 Apr, 2026, 01.06 PM IST
- Merck braces for Keytruda patent loss with $6.7 billion Terns betMerck is acquiring Terns Pharma for $6.7 billion to strengthen its cancer drug pipeline, aiming to reduce reliance on its blockbuster Keytr...26 Mar, 2026, 01.13 AM IST
- Patent rejected for MNC’s cancer drug; generics likely to enter marketThe Indian Patent Office has rejected a patent application for AbbVie's cancer drug Venetoclax. The office cited a lack of inventive steps ...23 Jan, 2026, 12.51 PM IST
- Alembic Pharmaceuticals gets USFDA nod for generic blood cancer treatment drugAlembic Pharmaceuticals has secured final approval from the USFDA for its generic Dasatinib tablets. These tablets are used to treat certai...07 Nov, 2025, 02.45 PM IST
- What is Chronic Lymphocytic Leukemia? See details about the cancer that affected Hulk Hogan before his deathWhat is Chronic Lymphocytic Leukemia? This cancer affected Hulk Hogan before his death. Hogan’s death revealed he had chronic lymphocytic l...01 Aug, 2025, 12.01 AM IST
- Zydus Lifesciences gets USFDA nod for generic cancer treatment capsulesZydus Lifesciences Ltd has received final approval from the USFDA for its generic version of the cancer treatment drug Cyclophosphamide cap...14 Dec, 2023, 03.48 PM IST
- FDA gives second approval to Eli Lilly's drug for type of blood cancerEli Lilly said the health regulator gave the new approval to the drug for the treatment of chronic lymphocytic leukemia (CLL), a type of ca...02 Dec, 2023, 08.07 AM IST
- New study shows how blood cancer can progress, from chronic to aggressive, in someFor a small percentage, the slower-paced disease can transform into aggressive cancer.31 Dec, 2022, 07.42 PM IST
- Zydus Cadila gets tentative nod from USFDA to market cancer drug"Ibrutinib belongs to a class of drugs known as kinase inhibitors and is used to treat certain cancers, such as mantle cell lymphoma or mar...21 Jul, 2021, 04.12 PM IST
- Zydus Cadila gets USFDA nod to market generic cancer drugThe company has received final approval from the US Food and Drug Administration (USFDA) to market its product which is a generic version o...09 Apr, 2020, 01.07 PM IST
- US scientists find new possibility to cure leukemiaWashington, Nov 21 (IANS) A group of American scientists has found a new possibility to cure leukemia, a deadly disease that strikes patien...21 Nov, 2017, 04.17 PM IST
- Sun Pharma settles Novartis lawsuit over leukemia drugSun Pharmaceutical Industries Ltd said it was allowed to launch a generic version of Novartis' leukemia drug Gleevec in the US15 May, 2014, 11.12 AM IST
- Ex-J&J India head led fight against patentCancer Patients Aid Association is ironically headed by a former country head of a multi-national medical products company.02 Apr, 2013, 04.00 AM IST
- Novartis condemns Supreme Court's patent bid for cancer drugNovartis condemned the Supreme Court's dismissal of its patent bid for a blockbuster cancer drug, saying it "discourages future innovation".01 Apr, 2013, 02.18 PM IST
- Raising drug efficacy is an inventive step, Novartis tells SCNovartis on Tuesday claimed in the SC that any incremental change in drug efficacy would tantamount to being an inventive step.19 Sep, 2012, 06.00 AM IST
- Amgen to purchase Micromet for $1.16 bn for Leukemia drugAmgen, the world's largest biotechnology company, agreed to buy Micromet in a $1.16 billion deal to gain an experimental leukemia drug.27 Jan, 2012, 03.37 AM IST
Load More
